Founded in 2010 by Dr. Olivier Loget, DVM, ERT, CapEval Pharma provides pharmaceutical consultancy services from early pre-clinical to clinical development, specifically in the sectors of Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance. CapEval’s team of highly qualified pharmaceutical consultants, fluent in 3 languages, provides scientific advice and training to identify the best approach to move projects quickly through development and onto the commercial market. With experience working in the Biotech, Pharma and CRO sectors, CapEval is uniquely qualified to offer complete outsourcing management services for critical studies and product development. CapEval offers particular expertise in the fields of due diligence, assessment of both in- and out-licensing programs and gap analysis for determination of project value.
Tags: Non-clinical safety drug development toxcology ophthalmology consulting